The North America central lab market size accounted for USD 1.3 billion in 2025 and is predicted to touch around USD 2.22 billion by 2035, growing at a CAGR of 5.5% from 2026 to 2035. The market is mainly influenced by the large number of clinical trials , the rapid adoption of advanced diagnostics such as molecular testing and biomarkers, and the presence of leading pharmaceutical and biotech companies.

North America Central Lab Market Statical Scope

This market is vital for global clinical research as it ensures the reliability of complex multi-center trials and aids in fast drug development through cutting-edge technology. With its advanced infrastructure and significant R&D investment, it plays a key role in promoting personalized medicine and addressing the growing challenge of chronic diseases. The market is benefitting from the use of AI-driven diagnostics, high automation levels, and sophisticated data management systems.

North America Central Lab Market, By Services, 2025 (%)

• Genetic Services - Specialized services for genetic testing and analysis holds 18% share. These services are crucial for analyzing data on molecular, biomarker-driven, and gene-based therapies in clinical trials.
• Biomarker Services - Services focusing on identifying biological markers for disease detection and treatment dominate with a 39% share. They play an essential role in speeding up personalized medicine, improving the effectiveness of clinical trials, and allowing for early disease diagnosis.

North America Central Lab Market, By End-use, 2025 (%)

• Pharmaceutical Companies - Pharmaceutical Companies represent a 45% share, driven by high demand for research, clinical trials, and drug development. This segment promotes growth through significant R&D investments, which require standardized testing, biomarkers analysis, and complex assays for the clinical trials.
• Biotechnology Companies - Companies that concentrate on biotech innovations and products have a 30% share, benefiting from the increasing use of lab services in biotechnology and therapeutic development. They are a key driver due to the rising demand for specialized testing in cell and gene therapy , personalized medicine, and oncology , along with the fast-paced development of innovative drugs.

Top Companies in the North America Central Lab Market

• ACM Global Laboratories
• Labconnect
• Cerba Research
• Eurofins Scientific
• Medicover Integrated Clinical Services (MICS) (Synevo Central Labs
• Versiti (Cenetron)
• A.P. Møller Holding A/S (Unilabs)
• Ampersand Capital Partners (Pacific Biomarkers)
• Lambda Therapeutics Research Ltd
• Cirion Biopharma Research Inc.

Segments Covered in the Report

By Services

• Genetic Services
• Biomarker Services
• Microbiology Services
• Anatomic Pathology/ Histology
• Specimen Management & Storage
• Special Chemistry Services
• Others

By End-use

• Pharmaceutical companies
• Biotechnology Companies
• Academic and Research Institutes